|
Eli Lilly & Co.
(LLY)
|
| |
| Sector: |
Healthcare |
| Industry: |
Drug Manufacturers - Major |
| Stock Type: | Aggressive Growth |
| Top Industry Grower: | WX |
LLY was last updated 16 days 9 hours 37 minutes ago. Use MrStockQuickie's
Free Value Investor Tool to view this data in real time.
The Numbers
| metric | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | TTM |
|---|
| Return on Capital | 31.0% | 36.9% | 38.4% | 29.4% | 23.0% | 19.2% | 12.4% | 11.9% | 18.5% | 17.9% | 13.2% |
| Equity/Share | $3.95 | $4.53 | $5.52 | $6.52 | $7.64 | $9.04 | $10.02 | $9.87 | $10.11 | $12.55 | $12.54 |
| Earnings/Share | $1.87 | $2.30 | $2.79 | $2.58 | $2.50 | $2.37 | $1.66 | $1.83 | $2.45 | $2.71 | $2.20 |
| FCF/Share | $1.97 | $1.89 | $2.79 | $2.55 | $0.87 | $1.80 | $0.89 | $0.56 | $2.67 | $3.74 | $0.00 |
| Sales/Share | $8.24 | $9.04 | $9.92 | $10.59 | $10.23 | $11.65 | $12.71 | $13.40 | $14.45 | $17.11 | $18.57 |
| Gross Margin | 78.2% | 79.0% | 81.1% | 81.3% | 80.4% | 78.7% | 76.7% | 76.3% | 77.4% | 77.2% | 76.7% |
The Trends
long term trend
| ROIC | BVPS | EPS | FCFPS | SPS |
|---|
| -3% | 3% | -0% | -1% | 2% |
|
growth acceleration trend
| ROIC | BVPS | EPS | FCFPS | SPS |
|---|
| -2% | -1% | -1% | 30% | 1% |
|
Quick Financial Health
ebit/interest [on debt]
| LLY | EQUITY_INDUSTRY | market |
|---|
| 1,939.40 | 187.10 | 58.10 |
|
cash/debt
| 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | TTM |
|---|
| 1.11 | 0.86 | 1.32 | 1.07 | 0.42 | 0.75 | 0.44 | 0.29 | 1.07 | 1.03 |
|
|
equity/debt
| 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | TTM |
|---|
| 2.04 | 1.79 | 2.27 | 2.27 | 1.89 | 2.08 | 2.44 | 1.89 | 3.12 | 2.94 | 2.7 |
|
|
assets/liabilities
| 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | TTM |
|---|
| 1.54 | 1.64 | 1.7 | 1.76 | 1.77 | 1.82 | 1.78 | 1.78 | 2.0 | 2.04 | 1.98 |
|
|
The Ratios
PEG
| Entity | Current | Next Year (Current PE) | Next Year (Forward PE) | Five Year |
|---|
| LLY | 1.33 | 3.63 | 1.96 | 1.36 | | Industry | 0.93 | 1.49 | 1.31 | 8.31 | | Market | 0.40 | 0.68 | 0.69 | 1.07 |
|
Valuations
| Entity | Price/Earnings | Price/Book | Price/Sales | Price/Cash Flow | Div. Yield (%) |
|---|
| LLY | 17.3 | 3.2 | 2.1 | 5.9 | 4.9 | | Industry | 16.7 | 3.0 | 2.6 | 9.8 | 1.3 | | Market | 13.0 | 2.9 | 1.7 | 9.1 | 3.2 |
|
The Pricing Metrics
Growth Rates
| Zacks | Reuters | Thomson Fin. | BVPS | EPS | FCFPS | SPS |
|---|
| 7.1% | 7.6% | 5.9% | 9.8% | 2.5% | 8.9% | 9.5% | | Next Year's Growth Estimate | 4.8% | | Priced-In Growth | 7.3% | | Intrinsic Growth | 8.1% |
|
Mulitple History
| 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | TTM |
|---|
| 38.3 | 32.9 | 28.2 | 30.8 | 26.0 | 26.9 | 39.6 | 30.0 | 22.5 | 20.5 | 17.4 | | Front Loaded Estimate | 20.0 | | High Growth Estimate | 14.6 | | Five Year Avgerage | 27.2 |
|
Quality and Value
Quality (0-10)
| Inferior | Low | Below Avg. | Average | Above Avg. | High | Superior |
|---|
| | | | 8.0 | | | |
|
Valuations
| | PE | EPS | PRICE | VALUE/PRICE | MOS |
|---|
| Current Price | 17.3 | $2.21 | $38.26 | 1.000 | 0.0% | | Intrinsic Value | 14.1 | $2.29 | $32.19 | 0.841 | -18.9% | | Price Adjusted for Industry | 14.8 | $2.21 | $32.72 | 0.855 | -16.9% | | Price Adjusted for Market | 13.2 | $2.21 | $29.08 | 0.760 | -31.6% | | EPS estimated FY08 Price | 17.4 | $4.00 | $69.48 | 1.816 | 44.9% | | EPS Quality (OIPS/E) | 2.96 | | Cash Quality (FCFPS/EPS) | 2.49 | | Short % of Float | 1.0% |
|
